Pacemaker and tricuspid valve health: long-term outcomes
Part of Heart & circulation clinical trials.
This study looks at how pacemakers and similar heart devices affect the tricuspid valve over time and whether that leads to worse health outcomes. It may help you understand if your device is causing long-term changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have an implantable electronic heart device, like a pacemaker or defibrillator.
- Your device was implanted at Qianfoshan Hospital between 2015 and 2025.
- You did not have severe tricuspid valve leakage or surgery on that valve before getting the device.
- You do not have severe heart valve disease, a congenital heart defect, or a serious irregular heartbeat.
- Your pacemaker is not a single-chamber type (it has more than one lead).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how heart devices like pacemakers affect the tricuspid valve over time. It uses ultrasound to check valve function and see if the device causes any problems.
This study looks at how a new pacemaker or defibrillator lead may affect the tricuspid valve (the valve between the right upper and lower heart chambers). It helps doctors understand if the lead causes leakage (regurgitation) over time.
This study compares newer pacemaker types to see how well they work and how they affect your heart's pumping ability and valve function over a short period. You'll be monitored closely with heart imaging to understand which pacemaker performs best.
This study looks at older adults with severe tricuspid regurgitation (a leaky heart valve) who either had a repair procedure with the PASCAL Precision system or received medication only. It helps us understand which approach may work better for people over 65.
This study looks at whether fixing the tricuspid valve at the same time as left heart surgery is beneficial for patients with mild tricuspid regurgitation. It may help improve heart function and reduce future symptoms.
This study looks back at patients who were successfully treated with TricValve bicaval valve devices and then follows up with their outcomes. You might join if you (or your legal guardian) agree to be included.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.